Advertisement.

VTGN Projected Dividend Yield

Com Par $/VistaGen Therapeutics Inc ( NASDAQ : VTGN )

Vistagen Therapeutics is a late clinical-stage biopharmaceutical company engaging in the treatment for individuals living with anxiety, depression and other central nervous system disorders. Co.'s product candidates include: fasedienol (PH94B), which is used for treatment of social anxiety disorder; Itruvone (PH10), which is used for depression disorders; PH80, which is used for treatment of both vasomotor symptoms (hot flashes) due to menopause and migraine headaches; PH15, which is used for treatment to improve cognitive impairment caused by mental fatigue and other disorders; and AV-101, which is an oral prodrug that targets the N-methyl-D-aspartate receptor.

20 YEAR PERFORMANCE RESULTS

VTGN Dividend History Detail
VTGN Dividend News
VTGN Competitors News

# of Shares: 0

Closing Price: 2.43

Current Market Value: 0.00

Cost Basis: 0.00

Date Acquired:

Dividend Cash Flow
Year	Annual Dividend	Dividend Growth	# of Shares	Annual Dividend Income	Yield On Cost %
2014	0.00	0%	0	$ 0.00	0.00%
2015	0.00	0%	0	$ 0.00	0.00%
2016	0.00	0%	0	$ 0.00	0.00%
2017	0.00	0%	0	$ 0.00	0.00%
2018	0.00	0%	0	$ 0.00	0.00%
2019	0.00	0%	0	$ 0.00	0.00%
2020	0.00	0%	0	$ 0.00	0.00%
2021	0.00	0%	0	$ 0.00	0.00%
2022	0.00	0%	0	$ 0.00	0.00%
2023	0.00	0%	0	$ 0.00	0.00%
2024	0.00	0%	0	$ 0.00	0.00%
2025	0.00	0%	0	$ 0.00	0.00%
Using the current years Dividend Growth rate of 0% and projecting 0% forward the annual dividend income in 10/yrs would be $ 0.00 with a yield on cost % of 0.00%
Rolling Last 4 qtrs dividends total $ 0.00 and Previous last 4 qtrs dividends total $ 0.00
Dividend 1 Yr Growth = ( 0.00 – 0.00 ) × 100 = 0% (Click the Edit pencil if you want to modify the forward dividend growth rate projection) 0.00

Year	Declaration Date	Ex-Dividend Date	Record Date	Payable Date	Dividend $ Amount
Total:					0.0000